Scarica l'app Stockscreener
0.73
7.59%
-0.06
Dopo l'orario di chiusura:
.79
0.06
+8.22%
Precedente Chiudi:
$0.79
Aprire:
$0.82
Volume 24 ore:
41,359
Relative Volume:
1.13
Capitalizzazione di mercato:
$4.68M
Reddito:
-
Utile/perdita netta:
$-21.13M
Rapporto P/E:
-0.1524
EPS:
-4.79
Flusso di cassa netto:
$-16.95M
1 W Prestazione:
-18.39%
1M Prestazione:
-40.16%
6M Prestazione:
-13.10%
1 anno Prestazione:
+28.52%
Intervallo 1D:
$0.7229
$0.8363
Intervallo di 1 settimana:
$0.7229
$0.975
Portata 52W:
$0.4748
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Nome
Matinas Biopharma Holdings Inc
Settore
Industria
Telefono
908-443-1860
Indirizzo
1545 Route 206 South, Suite 302, Bedminster, NJ
Confronta MTNB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.73 | 5.06M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-05-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Ripresa | Piper Sandler | Overweight |
| 2020-01-27 | Iniziato | Piper Sandler | Overweight |
| 2020-01-24 | Iniziato | SunTrust | Buy |
| 2020-01-23 | Iniziato | SunTrust | Buy |
| 2020-01-09 | Iniziato | Aegis Capital | Buy |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Matinas Biopharma Holdings Inc Borsa (MTNB) Ultime notizie
Matinas BioPharma amends CEO employment agreement to revise retention bonus terms - Investing.com Canada
Matinas BioPharma Amends CEO Employment Agreement - TipRanks
Matinas BioPharma amends CEO employment agreement to revise retention bonus terms By Investing.com - Investing.com South Africa
Matinas BioPharma CFO Resignation Announced - MSN
Forecast Cut: Will Matinas BioPharma Holdings Inc stock gain from strong economyMarket Rally & AI Enhanced Market Trend Forecasts - BỘ NỘI VỤ
How Matinas Biopharma Holdings Inc. stock reacts to stronger dollarJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - Newser
What insider trading reveals about Matinas BioPharma Holdings Inc. stockQuarterly Market Review & Accurate Buy Signal Notifications - Newser
Why Matinas Biopharma Holdings Inc. stock attracts wealthy investorsPortfolio Gains Report & Proven Capital Preservation Methods - Newser
Will Matinas BioPharma Holdings Inc. stock gain from strong economyEarnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
Will Matinas Biopharma Holdings Inc. stock sustain uptrend momentum2025 Year in Review & Fast Entry and Exit Trade Plans - Newser
How Matinas BioPharma Holdings Inc. (6LJ0) stock reacts to new regulationsTake Profit & Intraday High Probability Setup Alerts - Newser
Is Matinas Biopharma Holdings Inc. stock a top hedge fund pickOil Prices & High Return Trade Opportunity Guides - Newser
Why Matinas Biopharma Holdings Inc. stock benefits from AI revolutionQuarterly Profit Review & Risk Adjusted Buy and Sell Alerts - Newser
MTNB (Matinas BioPharma Holdings) Current Ratio : 3.78 (As of Sep. 2025) - GuruFocus
Matinas Biopharma Holdings Inc (MTNB) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Matinas BioPharma CFO Keith Kucinski to step down in January By Investing.com - Investing.com Australia
Matinas BioPharma CFO Keith Kucinski to step down in January - Investing.com
Matinas Biopharma Holdings IncCFO Keith Kucinski resigns effective January 17, 2026SEC filing - MarketScreener
[8-K] Matinas BioPharma Holdings, Inc. Reports Material Event | MTNB SEC FilingForm 8-K - Stock Titan
Will Matinas BioPharma Holdings Inc. (6LJ0) stock split increase liquidity2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com
Can Matinas Biopharma Holdings Inc. stock hold up in economic slowdown2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Why institutional investors increase stakes in Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
What hedge fund moves indicate for Matinas Biopharma Holdings Inc. stock2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - newser.com
Is Matinas BioPharma Holdings Inc. stock bottoming outWeekly Gains Report & Weekly Watchlist for Hot Stocks - newser.com
Why Matinas BioPharma Holdings Inc. stock could see breakout soonJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Will Matinas BioPharma Holdings Inc. (6LJ0) stock see insider accumulationDividend Hike & AI Enhanced Trade Execution Alerts - newser.com
Matinas Biopharma Holdings, Inc. (MTNB) 8.04% in After-hours: Modest Price Recovery - Stocks Telegraph
Is Matinas Biopharma Holdings Inc. stock undervalued after correctionQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com
How resilient is Matinas BioPharma Holdings Inc. stock in market downturns2025 Stock Rankings & Real-Time Volume Triggers - newser.com
Is Matinas Biopharma Holdings Inc. stock prepared for digital transitionJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - newser.com
How supply shortages influence Matinas BioPharma Holdings Inc. (6LJ0) stock - newser.com
Matinas Biopharma Holdings Inc Azioni (MTNB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):